JAGSNPHARMNSEJagsonpal Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Mon, 18 May · 18:07 IST

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP

Kmp ResignedDirector Flagged GovernanceManagement Changes View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹198.94
prior close
₹201.07
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2-0.5-1.5-1.3+0.1+6.6+5.1+3.9+4.1+3.5+3.0+7.1+12.1
Up moveDown movePending
AI summary

Mrs. Pallavi Dinodia Gupta has resigned as Independent Director of Jagsonpal Pharmaceuticals Limited effective May 18, 2026, citing personal reasons including increased professional commitments, personal engagements, and health considerations. She stated she can no longer devote sufficient time to her duties. With her departure, she also ceases to be a member of the Audit Committee, Corporate Social Responsibility Committee, and Chairperson of the Stakeholders Relationship Committee. She has confirmed there are no material reasons for her resignation beyond those stated. Mrs. Gupta serves as an Independent Director on three other listed companies: IndiaMART InterMESH Limited, Voith Paper Fabrics India Limited, and Lumax Industries Limited.

Likely market impact

The resignation reduces the board's independence and removes a director with committee leadership experience. Investors should monitor for replacement appointment, as this may temporarily weaken governance structures, especially with the loss of the Stakeholders Relationship Committee chair.